IOL Chemicals jumps 19% as FIIs raise stake in 2026

Stock hits over five-year high in intra-day trade

Shares of IOL Chemicals and Pharmaceuticals rose sharply in Tuesday’s intra-day trade, touching an over five-year high of ₹172.05 on the BSE. The move marked a 19% rally during the session and was accompanied by heavy volume, according to the data shared. The stock also traded close to its all-time high of ₹179.68, which was recorded on August 25, 2020. At 11:19 AM on Tuesday, the stock was quoted 16% higher at ₹167.85. Over the same time, the BSE Sensex was up 0.35%, highlighting the extent of outperformance on the day. The company is described as one of the leading Active Pharmaceutical Ingredient (API) manufacturers. The trading action drew attention because it combined a sharp price move with strong participation.

How the recent rally compares with the broader market

The stock’s recent run has been steep relative to the benchmark. Over the past month, IOL Chemicals’ price appreciated 36%, while the BSE Sensex rose 7% over the same period. The rally also looks dramatic over a longer window: since April 2026, the stock more than doubled, rising 136% from ₹72.75 on the BSE to the levels cited in the update. Another performance snapshot in the provided data set described shorter-term momentum as well, including a four-day winning streak of 12.03%. It also listed a one-year return of 52.18% in one section and 56.93% in another, both indicating strong gains over the last 12 months. The same snapshot referenced a Sensex one-year return of -7.98%. These comparisons were presented alongside technical commentary that the stock was in an uptrend.

Market snapshot: price levels and 52-week range

A separate market snapshot included exchange identifiers and end-of-day pricing context. The stock was shown at ₹144.10 at 03:17 PM on the BSE, up ₹1.05 (0.73%). The day’s high and low in that snapshot were ₹148.45 and ₹142.85, respectively. The 52-week high and low were listed as ₹151.05 and ₹67.14, respectively. Another line item in the same collection mentioned a “New 52-Week High” of ₹147.5 dated 1 July 2026, alongside the same 52-week low of ₹67.14. While the figures come from different points in the compiled text, both indicate the stock has been operating near the top of its recent trading range.

FII ownership rises sharply in June 2026

Shareholding changes were a key part of the narrative. As per the June 2026 shareholding pattern cited, foreign institutional investors (FIIs) increased their stake by 3.15 percentage points to 4.87%. The same data set stated that FIIs held 1.72% at the end of the March 2026 quarter. The June 2026 breakdown also listed Foreign Portfolio Investors (Category I) at 3.65% (from 1.62%) and Foreign Portfolio Investors (Category II) at 1.22% (from 0.10%). The text frames this increase as a notable shift in the shareholder base over one quarter. In parallel, resident individuals’ shareholding declined to 26.93% in the June quarter from 31.04% at the end of March.

Promoter holding and promoter group activity

The material includes multiple promoter-related data points. One section states that promoters increased holding from 57.48% to 62.28% in the June 2026 quarter. Another table of quarterly holdings up to March 2026 shows promoters at 57.48% in March 2026 versus 52.62% in earlier quarters listed, and investors at 42.52% in March 2026. The text also reports that promoters hold no encumbrance on shares as of June 6, 2026. Separately, it notes that promoter holding increased by 9.65% over the last six months. Taken together, the article’s data points emphasize rising promoter ownership alongside increased foreign participation.

Disclosed transactions: NCVI, NM Merchantiles, and Mayadevi

The compilation includes specific promoter-group transactions and corporate disclosures. NCVI Enterprises Limited acquired an additional 4,04,305 equity shares through open market transactions on March 19, 2026, after buying 7,00,000 shares on March 18. This increased NCVI’s direct shareholding to 4,86,55,000 shares and raised total promoter group holding to 57.48% from 57.34%, as stated. Another disclosure line says NCVI Enterprises increased its stake to 16.44% (from 16.20%) via an on-market purchase of 7,00,000 shares on March 18, 2026, disclosed under SEBI PIT regulations. The text also says NM Merchantiles Limited acquired 1,17,41,100 equity shares through a merger with Vasudeva Commercials Limited, increasing its shareholding from 13.08% to 17.08%.

A Hindi-language excerpt adds that Mayadevi Polycot Limited bought 54,197 equity shares on March 18, 2026, for a total value of ₹40 lakh (₹0.40 crore). It further states that earlier in March 2026, Mayadevi bought 6,54,123 shares on March 17 and NCVI Enterprises bought 7,00,000 shares on March 16, taking promoter group holding to 56.86% after those earlier purchases. These are described as incremental additions rather than a single large strategic change.

Quarterly fundamentals cited alongside the price move

The rally was also linked in the text to improving operating numbers. The company reported its highest-ever quarterly net sales of ₹619.45 crore and Profit After Tax (PAT) of ₹53.16 crore, which was described as a 71.1% increase versus the previous four-quarter average. Profit Before Tax (PBT) excluding other income reached ₹68.97 crore, reflecting 89.7% growth compared to the previous four-quarter average, according to the same dataset. PBDIT was reported at a record ₹92.47 crore. Another operating summary stated Q4 revenue was ₹619 crore and Q4 EBITDA was ₹94 crore, with a 15.2% margin. Management attributed the results to operational efficiencies, improved product mix, and higher capacity utilisation rather than one-off inventory gains, and expected improved levels to hold for the next one to two quarters, as per the text.

Technical indicators and the “Buy” call referenced

The technical commentary in the material was strongly positive. It stated the stock was trading above key moving averages including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. It also referenced signals across MACD, Bollinger Bands, KST, OBV, and moving averages as supporting the uptrend. A “Buy” rating was mentioned, along with a revision date of 08 June 2026 when the Mojo Score increased from 62 to 70. The same dataset highlighted a low debt profile, listing an average debt-to-equity of 0.01 times and a PEG ratio of 0.7. These indicators were presented as context for why momentum and fundamentals were being discussed together.

Key numbers at a glance

Timeline of promoter-group activity cited

Additional context: business profile and reported USD figures

IOL Chemicals and Pharmaceuticals Ltd. is described as a manufacturer of bulk drugs, specialty chemicals, and intermediates, with a focus on research and development and products meeting international standards. The text also included a separate disclosure that, as of December 2025, the company reported trailing 12-month revenue of $15.4 crore (derived from $154 million) and total debt of $1.3683 crore (derived from $13,683 thousand). These USD figures were presented alongside the India-market trading and shareholding data, adding another datapoint on scale and leverage. The combination of low leverage metrics cited elsewhere and these debt figures was used in the narrative to frame balance sheet comfort.

What investors will track next

The information set points to three immediate variables investors are likely to monitor: whether elevated volumes persist after the sharp up-move, whether the changes in institutional and promoter ownership continue in subsequent disclosures, and whether the company maintains the improved quarterly run referenced in the update. The text also flags that management expectations were tied to holding the improved operating levels for the next one to two quarters. For the market, the key near-term reference points remain the stock’s proximity to its August 2020 all-time high and the evolving 52-week range cited across different snapshots. Any further corporate announcements under SEBI disclosure norms, particularly around promoter transactions and quarterly results, are likely to remain in focus.